Moses H Cone Memorial Hosp

Greensboro, North Carolina 27401

0 studies enrolling now · 14 studies all time

What they study most

HIV Infections, Lipodystrophy, Tuberculosis

Studies at this site

• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months — Completed
• A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine — Completed
• A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3) — Completed
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients — Completed
• Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection — Completed
• A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients — Completed
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids — Completed
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients — Completed
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 — Completed
• A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients — Withdrawn before enrolling
• Long-Term Data Collection From Participants in Adult AIDS Clinical Trials — Completed
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects — Completed
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection — Completed
• A Comparison of Two Tests for Anti-HIV Drug Resistance — Completed